Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 16, 2007, Pages 6770-6775

  Roberts, Scott J ^a   Ng, Bernice Y ^a   Filler, Renata B ^a   Lewis, Julia ^a   Glusac, Earl J ^a   Hayday, Adrian C ^b   Tigelaar, Robert E ^a   Girardi, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

IFN ; Inflammation; Squamous cell carcinoma; T cell receptor

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CYCLOOXYGENASE 2; GAMMA INTERFERON; L SELECTIN; PERFORIN; PHORBOL 13 ACETATE 12 MYRISTATE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR NECROSIS FACTOR ALPHA; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CANCER MODEL; CD8+ T LYMPHOCYTE; CELL ISOLATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; INFLAMMATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TISSUE GROWTH; TUMOR ASSOCIATED LEUKOCYTE; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; GENETICS; IMMUNE DEFICIENCY; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MOUSE MUTANT; NEWBORN; PATHOLOGY; SKIN TUMOR; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION;

MUS;

ANIMALS; ANIMALS, NEWBORN; CD8-POSITIVE T-LYMPHOCYTES; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOPHENOTYPING; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SKIN NEOPLASMS; T-LYMPHOCYTE SUBSETS;

EID: 34249847072     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0604982104     Document Type: Article

References (32)

1. Mueller MM (2006) Eur J Cancer 42:735-744.
2. Virchow R (1863) Die Krankhaften Geschwulste (von August Hirschwald, Berlin), pp 57-101.
3. DePinho RA, Polyak K (2004) Nat Genet 36:932-934.
4. Balkwill F, Mantovani A (2001) Lancet 357:539-545.
5. Ikeda H, Old LJ, Schreiber RD (2002) Cytokine Growth Factor Rev 13:95-109.
6. Girardi M, Oppenheim D, Glusac EJ, Filler R, Balmain R, Tigelaar RE, Hayday AC (2004) J Invest Dermatol 122:699-706.
7. He YF, Wang XH, Zhang GM, Chen HT, Zhang H, Feng ZH (2005) Cancer Immunol Immunother 54:891-897.
8. Beatty GL, Paterson Y (2000) J Immunol 165:5502-5508.
9. Smyth MJ, Cretney E, Kershaw MH, Hayakawa Y (2004) Immunol Rev 202:275-293.
10. Philip M, Rowley DA, Schreiber H (2004) Semin Cancer Biol 14:433-439.
11. Nickoloff BJ, Ben-Neriah Y, Pikarsky E (2005) J Invest Dermatol 1246:10-14.
12. Owens DM, Wei S, Smart RC (1999) Carcinogenesis 20:1837-1844.
13. Muller-Decker K, Neufang G, Berger I, Neumann M, Marks F, Furstenberger G (2002) Proc Natl Acad Sci USA 99:12483-12488.
14. Tiano HF, Loftin CD, Akunda J, Lee CA, Spalding J, Sessoms A, Dunson DB, Rogan EG, Morham SG, Smart RC, Langenbach R (2002) Cancer Res 62:3395-3401.
15. Murakami A, Nakamura Y, Torikai K, Tanaka T, Koshiba T, Koshimizu K, Kuwahara S, Takahashi Y, Ogawa K, Yano M, et al. (2000) Cancer Res 60:5059-5066.
16. Marks F, Furstenberger G, Neufang G, Muller-Decker K (2003) Recent Results Cancer Res 163:46-57, discussion 264-266.
17. Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac F, Filler R, Hobby P, Sutton B, Tigelaar RE, Hayday AC (2001) Science 294:605-609.
18. Girardi M, Glusac E, Filler RB, Roberts SJ, Lewis J, Tigelaar RE, Hayday AC (2003) J Exp Med 198:747-755.
19. Yu P, Lee Y, Liu W, Krausz T, Chong A, Schreiber H, Fu YX (2005) J Exp Med 201:779-791.
20. Ghiringhelli F, Menard C, Terme M, Flament C, Taieb J, Chaput N, Puig PE, Novault S, Escudier B, Vivier E, et al. (2005) J Exp Med 202:1075-1085.
21. Waldmann TA (2006) Annu Rev Med 57:65-81.
22. Siegel CT, Schreiber K, Meredith SC, Beck-Engeser GB, Lancki DW, Lazarski CA, Fu YX, Rowley DA, Schreiber H (2000) J Exp Med 191:1945-1956.
23. Daniel D, Meyer-Morse N, Bergsland EK, Dehne K, Coussens LM, Hanahan D (2003) J Exp Med 197:1017-1028.
24. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY (2005) Immunity 22:329-341.
25. Ashkar AA, Di Santo JP, Croy BA (2000) J Exp Med 192:259-269.
26. Peto J (2001) Nature 411:390-395.
27. Prehn RT (1972) Science 176:170-171.
28. Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, Holdsworth H, Turner L, Rollins B, Pasparakis M, et al. (1999) Nat Med 5:828-831.
29. Tiano HF, Loftin CD, Akunda J, Lee CA, Spalding J, Sessoms A, Dunson DB, Rogan EG, Morham SG, Smart RC, Langenbach R (2002) Cancer Res 62:3395-3401.
30. Hanada T, Kobayashi T, Chinen T, Saeki K, Takaki H, Koga K, Minoda Y, Sanada T, Yoshioka T, Mimata H, et al. (2006) J Exp Med 203:1391-1397.
31. Enzler T, Gillessen S, Manis JP, Ferguson D, Fleming J, Alt FW, Mihm M, Dranoff G (2003) J Exp Med 197:1213-1219.
32. Schaerli P, Ebert L, Willimann K, Blaser A, Roos RS, Loetscher P, Moser B (2004) J Exp Med 199:1265-1275.